Glucagon helps treat hypoglycemia in type 1 diabetes
Glucagon is a well-established and vital treatment for severe hypoglycemia, particularly in patients with type 1 diabetes.
The retrieved papers consistently state that glucagon (in injectable, nasal, or inhaled forms) is an important and effective treatment for severe hypoglycemia in patients with type 1 diabetes. No papers contradict this.
Teresa Pearson. Glucagon as a Treatment of Severe Hypoglycemia. 2008. https://doi.org/10.1177/0145721707312400
This article reviews the critical role of glucagon as an essential treatment for severe hypoglycemia in type 1 diabetes.
See more details
Salva Heba, Uzma Parveen, Sara Khanum, Maaria Gulnaaz, Maimuna Tabassum, Syeda Safiyya. Nasal glucagon: A new hope for severe hypoglycemia in type 1 diabetes. 2021. https://doi.org/10.4103/jdep.jdep_6_20
This study highlights nasal glucagon as an efficient, easy-to-administer advancement in managing severe hypoglycemia in type 1 diabetes.
Salva Fatima Heba, Uzma Parveen, Sara Sana Ayesha Khanum, Maaria Gulnaaz, Maimuna Tabassum, Syeda Batool Safiyya. Inhaled Glucagon. 2021. https://doi.org/10.4103/jod.jod_26_20
This paper discusses intranasal glucagon as a favorable and convenient substitute to injections for treating severe hypoglycemia.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt